Hi all,
Has anyone started using zenocutuzumab? There are different recommendations for infusion duration between the eNRGy1 study and FDA approval - eNRGy1 infused over 4 hours for first dose and then dropped to 2 hours for subsequent doses if no IRR Grade > 2, while FDA approved as 4 hours and does not mention reducing the infusion time. It seems reasonable to me to reduce the administration time for subsequent doses given the low rates of IRRs, but I was curious how others have implemented this or if anyone has further insight?
Thanks in advance!
Cami
------------------------------
Cami Andreini, PharmD, BCOP, CPP
Duke University Hospital
cla54@duke.edu------------------------------